Butterfly Network, Inc. (BFLY) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $4.9M sold). Latest close $6.08 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 13, 2026 · Congress to Nov 16, 2026.
Polen Capital Management — 1 tracked fund hold BFLY. See all holders.
Insiders bought on the open market (0 purchases, $0) vs 10 sales ($4.9M). Insider trading
GE HealthCare Technologies Inc. (GEHC) · KONINKLIJKE PHILIPS NV (PHG) · THERMO FISHER SCIENTIFIC INC. (TMO) · INTUITIVE SURGICAL INC (ISRG) · Medtronic plc (MDT) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Polen Capital Management | 0.03% | 480,502 | ADDED (+18.3%) Q3 filed Nov 13 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -27.5% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 247 of 8,857 filers |
| Long-only filers among them | 244 |
| Change vs 2026 Q1 | +13 net · 238 entered · 225 exited |
| Shares reported, all filers | 158,338,195 |
| Reported value, all filers | $1.4B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (SIC 3844) |
| Revenue · FY2025 | $97.6M |
| Net income · FY2025 | $-77.1M |
| Total assets · FY2025 | $296.5M |
| Shares outstanding | 247,124,365 |
| Market cap (at latest close) | $1.5B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Dec 31, 2025.
| Shares short · Oct 15, 2026 | 33,592,331 |
| Share of shares outstanding | 13.59% |
| Days to cover | 6.19 |
Shares short at recent settlements — Jul 31, 2026: 32.7M · Aug 14, 2026: 32.2M · Aug 31, 2026: 34.1M · Sep 15, 2026: 35.7M · Sep 30, 2026: 31.6M · Oct 15, 2026: 33.6M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Dec 31, 2025.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 672K · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 600 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Dec 31, 2025.
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 10 sales by 6 insiders ($4.9M).
Source: SEC Form 4 filings. Open-market transactions only.
Recent open-market trades
| Date | Insider | Role | Buy / Sell | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | ROTHBERG JONATHAN M | Sell | 359,382 | $6.20 | $2.2M | SEC filing | |
| Nov 11, 2026 | Doherty John N. | EVP, CFO | Sell | 50,000 | $7.00 | $350.0K | SEC filing |
| Oct 30, 2026 | DEVIVO JOSEPH | President & CEO | Sell | 90,600 | $7.01 | $634.9K | SEC filing |
| Oct 6, 2026 | DEVIVO JOSEPH | President & CEO | Sell | 35,790 | $10.02 | $358.6K | SEC filing |
| Oct 2, 2026 | Carlson Megan | CAO and SVP, Finance | Sell | 10,114 | $8.74 | $88.4K | SEC filing |
| Sep 23, 2026 | DEVIVO JOSEPH | President & CEO | Sell | 3,169 | $10.02 | $31.8K | SEC filing |
| Sep 22, 2026 | DEVIVO JOSEPH | President & CEO | Sell | 2,811 | $10.00 | $28.1K | SEC filing |
| Sep 4, 2026 | Cashman Steve | Chief Business Officer | Sell | 140,112 | $7.30 | $1.0M | SEC filing |
| Sep 4, 2026 | Carlson Megan | CAO and SVP, Finance | Sell | 13,804 | $7.30 | $100.8K | SEC filing |
| Sep 2, 2026 | Caezza Nicholas | Deputy General Counsel | Sell | 1,709 | $8.15 | $13.9K | SEC filing |
Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | DEVIVO JOSEPH | Officer, Director | 35,790 | $358.6K | Oct 6, 2026 | SEC filing |
| Oct 2, 2026 | Carlson Megan | Officer | 10,114 | $88.4K | Oct 2, 2026 | SEC filing |
| Sep 23, 2026 | DEVIVO JOSEPH | Officer, Director | 3,169 | $31.8K | Sep 23, 2026 | SEC filing |
| Sep 23, 2026 | Schwartz Erica | Former Director | 323,020 | $3.2M | Sep 23, 2026 | SEC filing |
| Sep 22, 2026 | DEVIVO JOSEPH | Officer, Director | 2,811 | $28.1K | Sep 22, 2026 | SEC filing |
| Sep 22, 2026 | Schwartz Erica | Former Director | 78,679 | $786.8K | Sep 22, 2026 | SEC filing |
| Sep 4, 2026 | Cashman Steve | Officer | 140,112 | $1.0M | Sep 4, 2026 | SEC filing |
| Sep 4, 2026 | Carlson Megan | Officer | 13,804 | $100.8K | Sep 4, 2026 | SEC filing |
| Sep 2, 2026 | Caezza Nicholas | Officer | 1,709 | $13.9K | Sep 2, 2026 | SEC filing |
| Aug 11, 2026 | Caezza Nicholas | Officer | 10,000 | $97.5K | Aug 11, 2026 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Form | Price change since disclosure |
|---|---|---|
| Aug 17, 2026 | SCHEDULE 13D/A | -36.1% (close Aug 18, 2026 → Nov 17, 2026) |
Reference close is the first trading day after the filing (Aug 18, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Rothberg Jonathan M. | SC 13D/A | 828,775 | 0.3% | Aug 14, 2026 | SEC filing |
| Aug 17, 2026 | GLENVIEW CAPITAL MANAGEMENT, LLC | SC 13D/A | 11,743,530 | 4.8% | Aug 13, 2026 | SEC filing |
| Aug 14, 2026 | Hood River Capital Management LLC | SC 13G | 13,190,130 | 5.6% | Jun 30, 2026 | SEC filing |
| Aug 7, 2026 | FMR LLC | SC 13G | 28,952,296.89 | 11.8% | Jul 31, 2026 | SEC filing |
| Jul 27, 2026 | BlackRock, Inc. | SC 13G/A | 18,274,786 | 7.8% | Jun 30, 2026 | SEC filing |
| Jul 21, 2026 | Rothberg Jonathan M. | SC 13D/A | 828,775 | 0.4% | Jul 21, 2026 | SEC filing |
| Jul 17, 2026 | Rothberg Jonathan M. | SC 13D/A | 828,775 | 0.4% | Jul 15, 2026 | SEC filing |
| Mar 26, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Mar 17, 2026 | Rothberg Jonathan M. | SC 13D/A | 3,548,159 | 1.6% | Mar 13, 2026 | SEC filing |
| Feb 17, 2026 | GLENVIEW CAPITAL MANAGEMENT, LLC | SC 13D/A | 14,335,055 | 6.3% | Feb 12, 2026 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).
Industry: X-Ray Apparatus & Tubes & Related Irradiation Apparatus (SIC 3844). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.
None of the members who traded this stock in the current window sit on these committees.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: 50 Lobbying Disclosure Act filings named this company as client, 2021–2026; most common issues: Health Issues (19), Science/Technology (16), Medical/Disease Research/Clinical Labs (8).
Federal contracts: no obligated amounts found for this ticker (USASpending, fiscal years 2021–2026).
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
· Top Relative Strength — Top 20% of the universe by 6-month return
Red Flags
· Distress Risk (Altman Z″) — Altman Z″-Score below 1.10
Key figures
· Distress Risk (Altman Z″) — Z″-Score: -5.51 · Working capital / assets: 0.62 · Retained earnings / assets: -2.96 · EBIT / assets: -0.29 · Equity / liabilities: 1.95
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Insider BEST — appeared in 2 of the last 20 quarterly lists; latest 2025 Q4, ranked #46 of 50.
Also held by the tracked funds that hold BFLY — ranked by lift, the co-holding pattern described in Methodology: GE HealthCare Technologies Inc. (GEHC) · KONINKLIJKE PHILIPS NV (PHG) · THERMO FISHER SCIENTIFIC INC. (TMO) · INTUITIVE SURGICAL INC (ISRG) · Medtronic plc (MDT) · WATERS CORP /DE/ (WAT) · BECTON DICKINSON & CO (BDX) · BOSTON SCIENTIFIC CORP (BSX).
8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.
| Filed | Items | Source |
|---|---|---|
| Oct 29, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 5, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 9.01 Financial Statements and Exhibits | SEC filing |
| Aug 11, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
GE HealthCare Technologies Inc. (GEHC) · Track Record: how the signals scored · Practice timing on BFLY
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.